127 related articles for article (PubMed ID: 7002356)
1. Controlled trial of aspirin in cerebral ischemia.
Fields WS; Lemak NA; Frankowski RF; Hardy RJ; Bigelow RH
Circulation; 1980 Dec; 62(6 Pt 2):V90-6. PubMed ID: 7002356
[TBL] [Abstract][Full Text] [Related]
2. Summary of design features: clinical trials of platelet-active drugs in cerebrovascular disease.
Friedman LM
Circulation; 1980 Dec; 62(6 Pt 2):V88-9. PubMed ID: 7002355
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of aspirin in cerebral ischemia.
Fields WS; Lemak NA; Frankowski RF; Hardy RJ
Stroke; 1977; 8(3):301-14. PubMed ID: 324036
[TBL] [Abstract][Full Text] [Related]
4. A randomized trial of aspirin and sulfinpyrazone in patients with threatened stroke. Results and methodologic issues.
Gent M; Barnett HJ; Sackett DL; Taylor DW
Circulation; 1980 Dec; 62(6 Pt 2):V97-105. PubMed ID: 7002357
[TBL] [Abstract][Full Text] [Related]
5. The European Stroke Prevention Study (ESPS): results by arterial distribution.
Sivenius J; Riekkinen PJ; Smets P; Laakso M; Lowenthal A
Ann Neurol; 1991 Jun; 29(6):596-600. PubMed ID: 1892362
[TBL] [Abstract][Full Text] [Related]
6. Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
Fields WS; Lemak NA; Frankowski RF; Hardy RJ
Stroke; 1978; 9(4):309-19. PubMed ID: 354098
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of aspirin in cerebral ischemia (AITIA study).
Fields WS; Lemak NA; Frankowski RF; Hardy RJ
Thromb Haemost; 1979 Feb; 41(1):135-41. PubMed ID: 384582
[No Abstract] [Full Text] [Related]
8. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
[TBL] [Abstract][Full Text] [Related]
9. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
[TBL] [Abstract][Full Text] [Related]
10. The aspirin myocardial infarction study: final results. The Aspirin Myocardial Infarction Study research group.
Circulation; 1980 Dec; 62(6 Pt 2):V79-84. PubMed ID: 7438383
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for stroke after acute coronary syndromes in the Orbofiban in Patients with Unstable Coronary Syndromes--Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study.
Smith EE; Cannon CP; Murphy S; Feske SK; Schwamm LH
Am Heart J; 2006 Feb; 151(2):338-44. PubMed ID: 16442896
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
13. Transient ischemic attacks.
Quan M; Puffer JC; Johnson RA
J Fam Pract; 1983 Nov; 17(5):883-4, 889, 892 passim. PubMed ID: 6355371
[TBL] [Abstract][Full Text] [Related]
14. [Medical or chirurgical treatment in transient cerebral ischemia? (author's transl)].
Fields WS
Rev Neurol (Paris); 1981; 137(5):305-18. PubMed ID: 7027407
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease.
Topol EJ; Easton D; Harrington RA; Amarenco P; Califf RM; Graffagnino C; Davis S; Diener HC; Ferguson J; Fitzgerald D; Granett J; Shuaib A; Koudstaal PJ; Theroux P; Van de Werf F; Sigmon K; Pieper K; Vallee M; Willerson JT;
Circulation; 2003 Jul; 108(4):399-406. PubMed ID: 12874182
[TBL] [Abstract][Full Text] [Related]
16. The role of the neurologist in the decline of stroke.
Whisnant JP
Ann Neurol; 1983 Jul; 14(1):1-7. PubMed ID: 6614869
[TBL] [Abstract][Full Text] [Related]
17. Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.
Biller J
J Neurol Sci; 2009 Sep; 284(1-2):1-9. PubMed ID: 19380153
[TBL] [Abstract][Full Text] [Related]
18. MATCH results: implications for the internist.
Lutsep HL
Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and the prevention of stroke after transient ischaemic attack.
Warlow C
Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
[No Abstract] [Full Text] [Related]
20. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
